AI IntelligenceMar 27, 2026M&A
Article
Nicht angegeben -> Pulmatrix, Inc.
Biopharmaceutical company Pulmatrix, Inc. filed a comprehensive 8-K indicating a significant change in control (Item 5.01). Additional items like entry into a material agreement (1.01) and unregistered sales of equity (3.02) strongly suggest an acquisition or change of control transaction. Details are not available from the summary.
Data Cube AI EditorialSource: SEC EDGAR
01
Source Brief
Biopharmaceutical company Pulmatrix, Inc. filed a comprehensive 8-K indicating a significant change in control (Item 5.01). Additional items like entry into a material agreement (1.01) and unregistered sales of equity (3.02) strongly suggest an acquisition or change of control transaction. Details are not available from the summary.
02